On Monday, the share price of the company hit its upper circuit of 5% at ₹762.65 per share from its previous close of ₹726.35 after the company announced its result and the investor presentation.
In the December quarter, the company’s net revenue increased by 92% YoY from ₹52 crores to ₹100 crores and increased 51% on a QoQ basis from ₹66 crores.
Zen Technology’s net profit rose by 150% YoY from ₹12 crores to ₹30 crores and on a QoQ basis, net profit increased by 114% from ₹14 crores.
Furthermore, according to the investor presentation, the company received a new order worth 129.08 crores in Q3FY24, as well as the import and export of training simulators, equipment, and anti-drone systems. The total order book value in December was ₹1,434.3 crores.
The company’s promoters hold a 57.07% stake in the company, with 4.65% owned by foreign institutional investors, 36.42% owned by the general public, and 3.09% percent owned by domestic institutional investors.
Zen Technology Limited is a small-cap company with a market capitalization of Rs 6,360 crores. It also has a return on equity (ROE) of 12% a return on capital employed (ROCE) of 17.3% and a net profit margin of 22.4%
Zen Technology Limited’s share price increased by 280% last year and by 23% In the last six months. For example, if an investor invested ₹1 lakh a year ago, the current value is ₹3.80 Lakhs.
Zen Technologies Limited was founded in 1993 and is a pioneer in providing Counter-Drone, vital infrastructure, and other areas. It also designs, develops, and produces cutting-edge Combat Training Solutions for training Defence & Security Forces worldwide.
Written by Sriram KV
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
